CYXO.ST
Price:
$0.018
Market Cap:
$6.75M
Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.
Industry
Biotechnology
IPO Date
2016-06-07
Stock Exchange
STO
Ticker
CYXO.ST
According to Cyxone AB (publ)’s latest financial reports and current stock price. The company's current ROE is -53.52%. This represents a change of 234.31% compared to the average of -16.01% of the last 4 quarters.
The mean historical ROE of Cyxone AB (publ) over the last ten years is -55.34%. The current -53.52% ROE has changed -3.29% with respect to the historical average. Over the past ten years (40 quarters), CYXO.ST's ROE was at its highest in in the March 2016 quarter at 0%. The ROE was at its lowest in in the December 2021 quarter at -35.65%.
Average
-55.34%
Median
-49.02%
Minimum
-114.78%
Maximum
-18.23%
Discovering the peaks and valleys of Cyxone AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 124.07%
Maximum Annual ROE = -18.23%
Minimum Annual Increase = -61.97%
Minimum Annual ROE = -114.78%
| Year | ROE | Change |
|---|---|---|
| 2023 | -59.01% | -34.77% |
| 2022 | -90.46% | -21.19% |
| 2021 | -114.78% | 57.19% |
| 2020 | -73.02% | 48.96% |
| 2019 | -49.02% | 124.07% |
| 2018 | -21.88% | -7.94% |
| 2017 | -23.76% | 30.37% |
| 2016 | -18.23% | -61.97% |
The current ROE of Cyxone AB (publ) (CYXO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-88.08%
5-year avg
-77.26%
10-year avg
-55.34%
Cyxone AB (publ)’s ROE is greater than Ziccum AB (publ) (-253.28%), less than Bonzun AB (publ) (55.56%), greater than Redwood Pharma AB (-98.20%), greater than Cline Scientific AB (publ) (-16.76%), greater than Scandion Oncology A/S (-139.19%), greater than Asarina Pharma AB (publ) (-157.86%), greater than Hemcheck Sweden AB (publ) (-50.87%), greater than Idogen AB (publ) (-652.21%), greater than Duearity AB (publ) (-1424.53%), greater than Pharmiva AB (publ) (-82.12%),
| Company | ROE | Market cap |
|---|---|---|
| -253.28% | $8.56M | |
| 55.56% | $7.25M | |
| -98.20% | $3.15M | |
| -16.76% | $3.11M | |
| -139.19% | $962.52K | |
| -157.86% | $633.96K | |
| -50.87% | $8.63M | |
| -652.21% | $12.79M | |
| -1424.53% | $3.08M | |
| -82.12% | $12.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyxone AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cyxone AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cyxone AB (publ)'s ROE?
How is the ROE calculated for Cyxone AB (publ) (CYXO.ST)?
What is the highest ROE for Cyxone AB (publ) (CYXO.ST)?
What is the 3-year average ROE for Cyxone AB (publ) (CYXO.ST)?
What is the 5-year average ROE for Cyxone AB (publ) (CYXO.ST)?
How does the current ROE for Cyxone AB (publ) (CYXO.ST) compare to its historical average?